Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

Por um escritor misterioso

Descrição

Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Frontiers CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Antibody drug conjugates in brain tumors – new kids on the block?
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Structure–Activity Relationships of Antibody-Drug Conjugates: A Systematic Review of Chemistry on the Trastuzumab Scaffold
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
JCM, Free Full-Text
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Unlocking the potential of antibody–drug conjugates for cancer therapy
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Towards Immunotherapy for Pediatric Brain Tumors: Trends in Immunology
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Construction and characterization of mAb–Ang2 conjugates. (A)
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors - ScienceDirect
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Biomedicines, Free Full-Text
de por adulto (o preço varia de acordo com o tamanho do grupo)